Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism ABCC9 inhibitors(ATP binding cassette subfamily C member 9 inhibitors), KCNJ8 inhibitors(potassium inwardly rectifying channel subfamily J member 8 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | US | 15 Feb 2024 |